Our Insights blog goes deeper into hot topics and critical world issues. Looking for more? Learn about how we integrate data and expert visualization services with our intelligent tools, custom situation rooms, and enterprise data portals.
BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.
This eighth, biennial report focuses on the economic progress and footprint of the industry geographically including the performance, positioning and latest trends in the bio-science industry for the nation, states and metropolitan areas. For the first time, it includes a national assessment of the full economic impact of the bio-science industry not only in terms of employment, but also with respect to economic output and fiscal impacts. In addition, the report details the nation’s academic research activities and trends in federal funding, access to critical angel and venture capital and the innovation outputs context via patent activities.
Access to early-stage financing is the lifeblood of biotechnology innovation. For therapeutic-focused biotechnology companies in particular, the required capital and development timelines dwarf most other industries, making it challenging to find sizable early investments from committed investors. As the world’s largest trade association representing biotechnology companies across the United States and in more than 30 other nations, it is important for BIO to better understand investor trends in order to determine where scientific or policy issues may be impacting the ability to maintain a robust pipeline of innovative medicines.
A Knoema é a fonte mais abrangente do mundo de business intelligence global. Nossas ferramentas permitem que indivíduos e organizações explorem, visualizem, modelem e apresentem seus dados e dados mundiais para facilitar melhores decisões e melhores resultados.